Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William C Florence

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Reviews in Molecular Medicine|July 8, 2008
CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequencesWilliam C Florence, Rakesh K Bhat, Sebastian Joyce
Journal of Leukocyte Biology|July 5, 2007
Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosisFatoumata B Sow, William C Florence, Abhay R Satoskar, et al.
Cell Host & Microbe|November 5, 2020
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and TherapeuticsJudith A Hewitt, Cathleen Lutz, William C Florence, et al.
Vaccines|September 28, 2021
Selection of Filovirus Isolates for Vaccine Development ProgramsDaniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, et al.
Journal of Leukocyte Biology|July 1, 2008
The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosomeKristopher E Van Zandt, Fatoumata B Sow, William C Florence, et al.
Vaccines|August 26, 2022
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine DevelopmentKimberly L Taylor, Lynda Lanning, Lawrence Wolfraim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivoChang-Yuan Ni, Zhao-Hui Wu, William C Florence, et al.
The EMBO Journal|October 10, 2009
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligandsWilliam C Florence, Chengfeng Xia, Laura E Gordy, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Reviews in Molecular Medicine|July 8, 2008
CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequencesWilliam C Florence, Rakesh K Bhat, Sebastian Joyce
Journal of Leukocyte Biology|July 5, 2007
Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosisFatoumata B Sow, William C Florence, Abhay R Satoskar, et al.
Cell Host & Microbe|November 5, 2020
ACTIVating Resources for the COVID-19 Pandemic: In Vivo Models for Vaccines and TherapeuticsJudith A Hewitt, Cathleen Lutz, William C Florence, et al.
Vaccines|September 28, 2021
Selection of Filovirus Isolates for Vaccine Development ProgramsDaniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, et al.
Journal of Leukocyte Biology|July 1, 2008
The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosomeKristopher E Van Zandt, Fatoumata B Sow, William C Florence, et al.
Vaccines|August 26, 2022
A U.S. Government-Coordinated Effort to Leverage Non-Human Primate Data to Facilitate Ebolavirus Vaccine DevelopmentKimberly L Taylor, Lynda Lanning, Lawrence Wolfraim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivoChang-Yuan Ni, Zhao-Hui Wu, William C Florence, et al.
The EMBO Journal|October 10, 2009
Adaptability of the semi-invariant natural killer T-cell receptor towards structurally diverse CD1d-restricted ligandsWilliam C Florence, Chengfeng Xia, Laura E Gordy, et al.
Nature|April 1, 2022
Defining the risk of SARS-CoV-2 variants on immune protectionMarciela M DeGrace, Elodie Ghedin, Matthew B Frieman, et al.
Pageof 1